(Q56109733)

6

Östen Ljunggren

0 references

Claes Ohlsson

Claes Ohlsson

5

0 references

Dan Mellström

3

Dan Mellström

0 references

Magnus K Karlsson

2

Magnus K Karlsson

0 references

author name string

Majd AI Mirza

1

0 references

Tobias E Larsson

Journal of Bone and Mineral Research

7

0 references

publication date

23 March 2011

0 references

published in

0 references

volume

26

0 references

issue

4

0 references

page(s)

857-864

0 references

cites work

FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting

1 reference

Regulation of fibroblastic growth factor 23 expression but not degradation by PHEX.

21 January 2018

1 reference

FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis

21 January 2018

1 reference

Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23

21 January 2018

1 reference

Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia

21 January 2018

1 reference

Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia

21 January 2018

1 reference

DMP1 mutations in autosomal recessive hypophosphatemia implicate a bone matrix protein in the regulation of phosphate homeostasis.

21 January 2018

1 reference

Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism.

21 January 2018

1 reference

Transgenic mice expressing fibroblast growth factor 23 under the control of the alpha1(I) collagen promoter exhibit growth retardation, osteomalacia, and disturbed phosphate homeostasis

21 January 2018

1 reference

FGF-23 transgenic mice demonstrate hypophosphatemic rickets with reduced expression of sodium phosphate cotransporter type IIa.

21 January 2018

1 reference

Relation between fibroblast growth factor-23, body weight and bone mineral density in elderly men.

21 January 2018

1 reference

Overexpression of fibroblast growth factor 23 suppresses osteoblast differentiation and matrix mineralization in vitro

21 January 2018

1 reference

Free testosterone is an independent predictor of BMD and prevalent fractures in elderly men: MrOS Sweden

21 January 2018

1 reference

Design and baseline characteristics of the osteoporotic fractures in men (MrOS) study--a large observational study of the determinants of fracture in older men.

21 January 2018

1 reference

Older men with low serum estradiol and high serum SHBG have an increased risk of fractures

21 January 2018

1 reference

Evaluation of Gentian cystatin C reagent on Abbott Ci8200 and calculation of glomerular filtration rate expressed in mL/min/1.73 m(2) from the cystatin C values in mg/L.

21 January 2018

1 reference

Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets/osteomalacia

21 January 2018

1 reference

Time-to-event analysis of longitudinal follow-up of a survey: choice of the time-scale

21 January 2018

1 reference

Gaining more flexibility in Cox proportional hazards regression models with cubic spline functions.

21 January 2018

1 reference

The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women.

21 January 2018

1 reference

A gene (PEX) with homologies to endopeptidases is mutated in patients with X-linked hypophosphatemic rickets. The HYP Consortium

21 January 2018

1 reference

Genetic evidence of serum phosphate-independent functions of FGF-23 on bone

21 January 2018

1 reference

Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers

21 January 2018

1 reference

Relationship between circulating FGF23 and total body atherosclerosis in the community

21 January 2018

1 reference

Serum intact FGF23 associate with left ventricular mass, hypertrophy and geometry in an elderly population

21 January 2018

1 reference

Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease

21 January 2018

1 reference

FGF-23 and vascular dysfunction in patients with stage 3 and 4 chronic kidney disease

21 January 2018

1 reference

Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis

21 January 2018

1 reference

Peripheral vascular calcification in long-haemodialysis patients: associated factors and survival consequences

21 January 2018

1 reference

Bone histology in incipient and advanced renal failure

21 January 2018

1 reference

Renal bone disease 1990: an unmet challenge for the nephrologist

21 January 2018

1 reference

Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease

21 January 2018

1 reference